Dr. Post is a strategic Regulatory Affairs leader with extensive experience in global pharmaceutical development, known for successfully navigating complex regulatory pathways across neurology and vaccines. Currently she is Head of Global Regulatory Affairs, Neurology, at Sanofi where she leads the Neurology Global Regulatory Affairs team and Regulatory Strategy development for programs within Sanofi’s Specialty Care business unit. Prior to this role, Dr. Post was Head of Regulatory Affairs Development, US Vaccines at Sanofi where she was responsible for the development and execution of US regulatory strategies for Sanofi’s vaccine pipeline and lifecycle assets in clinical development. Her proven track record includes progressing products from pre-clinical through global approval and post-marketing changes. She is the Regulatory head that led the team responsible for the filing and FDA approval of Flublok®, the world’s first marketed recombinant influenza vaccine. Dr. Post holds a B.A. in Biology from Middlebury College and a Ph.D. in Biochemistry and Cell Biology from Carnegie Mellon University.
